Evidence map›Paper›PMID 36722332›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Epidemiology of Invasive Nontypeable Haemophilus influenzae Disease-United States, 2008-2019.

Sara E Oliver, Amy B Rubis, Heidi M Soeters, Arthur Reingold, Meghan Barnes, Susan Petit, Monica M Farley, Lee H Harrison, Kathy Como-Sabetti, Sarah A Khanlian and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of bacteriology · 2026
    Review
  4. Article
  5. Article
  6. Whole-genome and pan-genome analyses reveal genomic differences among nontypeableFrontiers in cellular and infection microbiology · 2026
    Article
  7. Article
  8. Article
  9. Molecular detection ofNew microbes and new infections · 2025
    Article
  10. Article
  11. AASM case reports · 2025
    Article
  12. Article
  13. Inflammatory Responses to Non-TypeablePathogens (Basel, Switzerland) · 2025
    Article
  14. Article
  15. A Rare Presentation of Invasive NontypeableCase reports in infectious diseases · 2025
    Article
  16. Optimizing recovery of Haemophilus influenzae from vaginal-rectal specimens and determining carriage rates in pregnant women.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  17. Changing Landscape ofCase reports in infectious diseases · 2024
    Article
  18. Genome Characterisation of InvasivePathogens (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Sara E OliverNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Amy B RubisNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Heidi M SoetersNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Arthur ReingoldSchool of Public Health, University of California, Berkley, California, USA.
Meghan BarnesColorado Department of Public Health and Environment, Denver, Colorado, USA.
Susan PetitConnecticut Department of Public Health, Hartford, Connecticut, USA.
Monica M FarleyEmory University School of Medicine and Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
Lee H HarrisonBloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Kathy Como-SabettiMinnesota Department of Health, St Paul, Minnesota, USA.
Sarah A KhanlianNew Mexico Department of Health, New Mexico, USA.
Rachel WesterNew York State Department of Health, Albany, New York, USA.
Ann ThomasOregon Health Authority, Portland, Oregon, USA.
William SchaffnerDepartment of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Henju MarjukiNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Xin WangNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Susan HaririNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USNational Center for Immunization and Respiratory Diseases · USColorado Department of Public Health and Environment · USConnecticut Department of Public Health · USEmory University · USJohns Hopkins University · USMinnesota Department of Health · USNew Mexico Department of Health · USNew York State Department of Health · USOregon Health Authority · USVanderbilt University · US

Funding

CDC HHS CDC-RFA-CK12-120205CONT16Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundNontypeable Haemophilus influenzae (NTHi) is the most common cause of invasive H. influenzae disease in the United States (US). We evaluated the epidemiology of invasive NTHi disease in the US, including among pregnant women, infants, and people with human immunodeficiency virus (PWH).

methodsWe used data from population- and laboratory-based surveillance for invasive H. influenzae disease conducted in 10 sites to estimate national incidence of NTHi, and to describe epidemiology in women of childbearing age, infants aged ≤30 days (neonates), and PWH living in the surveillance catchment areas. H. influenzae isolates were sent to the Centers for Disease Control and Prevention for species confirmation, serotyping, and whole genome sequencing of select isolates.

resultsDuring 2008-⁠2019, average annual NTHi incidence in the US was 1.3/100 000 population overall, 5.8/100 000 among children aged <1 year, and 10.2/100 000 among adults aged ≥80 years. Among 225 reported neonates with NTHi, 92% had a positive culture within the first week of life and 72% were preterm. NTHi risk was 23 times higher among preterm compared to term neonates, and 5.6 times higher in pregnant/postpartum compared to nonpregnant women. More than half of pregnant women with invasive NTHi had loss of pregnancy postinfection. Incidence among PWH aged ≥13 years was 9.5 cases per 100 000, compared to 1.1 cases per 100 000 for non-PWH (rate ratio, 8.3 [95% confidence interval, 7.1-9.7]; P < .0001).

conclusionsNTHi causes substantial invasive disease, especially among older adults, pregnant/postpartum women, and neonates. Enhanced surveillance and evaluation of targeted interventions to prevent perinatal NTHi infections may be warranted.

Indexed as

Haemophilus InfectionsInfant, Newborn, DiseasesAgedChildFemaleHaemophilus influenzaeHumansIncidenceInfantInfant, NewbornPostpartum PeriodPregnancySerotypingUnited StatesepidemiologyHaemophilus influenzaeHaemophilus influenzae vaccinesnontypeable Haemophilus influenzae

Identifiers

PMID36722332
PMCPMC11320882
OpenAlexW4318755841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.